Animalcare Group PLC banner

Animalcare Group PLC
LSE:ANCR

Watchlist Manager
Animalcare Group PLC Logo
Animalcare Group PLC
LSE:ANCR
Watchlist
Price: 333 GBX Market Closed
Market Cap: £229.9m

Animalcare Group PLC
Intangible Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Animalcare Group PLC
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Animalcare Group PLC
LSE:ANCR
Intangible Assets
£42m
CAGR 3-Years
15%
CAGR 5-Years
0%
CAGR 10-Years
37%
GlaxoSmithKline PLC
LSE:GSK
Intangible Assets
£16.7B
CAGR 3-Years
5%
CAGR 5-Years
-11%
CAGR 10-Years
0%
AstraZeneca PLC
LSE:AZN
Intangible Assets
$37.8B
CAGR 3-Years
-1%
CAGR 5-Years
13%
CAGR 10-Years
5%
Hikma Pharmaceuticals PLC
LSE:HIK
Intangible Assets
$777m
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
2%
Allergy Therapeutics PLC
LSE:AGY
Intangible Assets
£931k
CAGR 3-Years
-18%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
A
Alliance Pharma PLC
LSE:APH
Intangible Assets
£240.9m
CAGR 3-Years
-14%
CAGR 5-Years
-5%
CAGR 10-Years
11%
No Stocks Found

Animalcare Group PLC
Glance View

Market Cap
229.9m GBX
Industry
Pharmaceuticals

Animalcare Group Plc engages in the development, sale, and supply of generic veterinary medicines and animal identification products. The company is headquartered in Ripon, North Yorkshire. The company went IPO on 2008-01-15. The firm is focused on developing and commercializing prescription and over-the-counter pharmaceutical products. The firm operates in three categories within the veterinary market, which includes Companion Animals, Equine and Production Animals. The company manages international supply chain, including specialist veterinary wholesalers and distributors. The firm develops, supplies and markets products and services to the veterinary profession. The company focuses on therapeutic areas, which includes pain management, dermatology and anti-infectives. The Company’s product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs.

ANCR Intrinsic Value
222.44 GBX
Overvaluation 33%
Intrinsic Value
Price GBX333

See Also

What is Animalcare Group PLC's Intangible Assets?
Intangible Assets
42m GBP

Based on the financial report for Jun 30, 2025, Animalcare Group PLC's Intangible Assets amounts to 42m GBP.

What is Animalcare Group PLC's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
37%

Over the last year, the Intangible Assets growth was 133%. The average annual Intangible Assets growth rates for Animalcare Group PLC have been 15% over the past three years , and 37% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett